Articles related to Oncology, Medical

Workplace exposure to harmful chemicals remains a significant risk factor for bladder cancer, particularly affecting specific occupations and requiring targeted prevention strategies.

Durvalumab consolidation therapy demonstrated unprecedented survival benefit in limited-stage SCLC, extending median overall survival by nearly two years compared to placebo.

Poor metabolizers of UGT1A1 face a significantly increased risk of severe neutropenia from irinotecan therapy, making genetic testing crucial for appropriate dose modification.

Large-scale analysis of 5.1 million individuals reveals distinct correlations between blood types and 49 different diseases, offering new perspectives for risk assessment in clinical practice.

Analysis of objective biomarkers in blood samples reveals that individuals with the highest levels of omega-3 or omega-6 fatty acids demonstrated 20% lower cancer mortality rates compared to those with the lowest levels.

The case highlights the critical importance of thorough documentation and appropriate follow-up care, regardless of a patient’s age or statistical likelihood of serious conditions.